Details for New Drug Application (NDA): 071188
✉ Email this page to a colleague
NDA 071188 describes RITODRINE HYDROCHLORIDE, which is a drug marketed by Abraxis Pharm and Hospira and is included in five NDAs. Additional details are available on the RITODRINE HYDROCHLORIDE profile page.
The generic ingredient in RITODRINE HYDROCHLORIDE is ritodrine hydrochloride. There are five drug master file entries for this compound. Additional details are available on the ritodrine hydrochloride profile page.
The generic ingredient in RITODRINE HYDROCHLORIDE is ritodrine hydrochloride. There are five drug master file entries for this compound. Additional details are available on the ritodrine hydrochloride profile page.
Summary for 071188
| Tradename: | RITODRINE HYDROCHLORIDE |
| Applicant: | Abraxis Pharm |
| Ingredient: | ritodrine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 071188
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 10MG/ML | ||||
| Approval Date: | Jul 23, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
